1993
DOI: 10.1016/0169-409x(93)90046-7
|View full text |Cite
|
Sign up to set email alerts
|

Nano- and microparticles for the delivery of polypeptides and proteins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
117
0
1

Year Published

2002
2002
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 255 publications
(119 citation statements)
references
References 59 publications
1
117
0
1
Order By: Relevance
“…32 In general, it is assumed that particles up to about 100-200 nm can be internalized by receptor-mediated endocytosis, while larger particles have to be taken up by phagocytosis. 33 The smaller-sized particles seem to have more efficient interfacial interactions with the cell membrane compared to larger-sized particles. 27 Therapeutic use of lipoparticles is of importance, since the small size of lipoparticles could improve efficacy of particle-based oral drug delivery systems and the smaller size could also improve the efficiency of cellular uptake, making these particles highly feasible for use in oral drug delivery therapy.…”
Section: Discussionmentioning
confidence: 99%
“…32 In general, it is assumed that particles up to about 100-200 nm can be internalized by receptor-mediated endocytosis, while larger particles have to be taken up by phagocytosis. 33 The smaller-sized particles seem to have more efficient interfacial interactions with the cell membrane compared to larger-sized particles. 27 Therapeutic use of lipoparticles is of importance, since the small size of lipoparticles could improve efficacy of particle-based oral drug delivery systems and the smaller size could also improve the efficiency of cellular uptake, making these particles highly feasible for use in oral drug delivery therapy.…”
Section: Discussionmentioning
confidence: 99%
“…Microparticles are a generic term to mention microcapsules and microspheres which can be made of polymers or lipids (liposomes) with sizes ranging from 1 to 250 µm (ideally <125 µm and exceptionally 1000 µm) [12,13]. This technology is very important in drug delivery.…”
Section: Type Of New Drug Carriers Systemsmentioning
confidence: 99%
“…The physicochemical properties of many peptides and proteins make their entrapment difficult, because inactivation is possible during their incorporation (Couvreur and Puisieux, 1993). Stability, solubility and sensitivity to light, heat, moisture and pH, intermolecular interactions following co-precipitation or gelling, and adsorption and interaction with excipients are parameters that should be investigated in order to succeed in producing a stable association of peptides with particle-based systems (Couvreur and Puisieux, 1993).…”
Section: Microparticle-based Systems As Scaffolds and Carriers For Bimentioning
confidence: 99%
“…The physicochemical properties of many peptides and proteins make their entrapment difficult, because inactivation is possible during their incorporation (Couvreur and Puisieux, 1993). Stability, solubility and sensitivity to light, heat, moisture and pH, intermolecular interactions following co-precipitation or gelling, and adsorption and interaction with excipients are parameters that should be investigated in order to succeed in producing a stable association of peptides with particle-based systems (Couvreur and Puisieux, 1993). While encapsulation of peptides and small molecules into biodegradable microspheres can be achieved using several techniques and with different polymers, the encapsulation of proteins still poses major difficulties with respect to obtaining 'infusion-like' or continuous-release profiles with minimal initial burst and sufficient protein loading within the microspheres (Kissel et al, 1996;Morlock et al, 1998).…”
Section: Microparticle-based Systems As Scaffolds and Carriers For Bimentioning
confidence: 99%